Comment
Antiplatelet prophylaxis. Consider the protective effect of blood loss from the gut
- PMID: 8148719
- PMCID: PMC2539723
Item in Clipboard
Comment
Antiplatelet prophylaxis. Consider the protective effect of blood loss from the gut
BMJ.
.
No abstract available
Comment on
-
Collaborative overview of randomised trials of antiplatelet therapy--III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration.BMJ. 1994 Jan 22;308(6923):235-46. BMJ. 1994. PMID: 8054013 Free PMC article.
Similar articles
-
Aspirin for prevention of myocardial infarction. A double-edged sword.Ann Med Interne (Paris). 1997;148(6):430-3. Ann Med Interne (Paris). 1997. PMID: 9538376
-
Who should be taking aspirin?Harv Heart Lett. 2002 Apr;12(8):3-5. Harv Heart Lett. 2002. PMID: 11959516 No abstract available.
-
Enteric coated aspirin.Am J Med. 2007 Apr;120(4):e9. doi: 10.1016/j.amjmed.2006.04.033. Am J Med. 2007. PMID: 17398216 No abstract available.
-
[Antiplatelet agents--problem for cardiac surgeon].Kardiol Pol. 2006 Nov;64(11):1329-31. Kardiol Pol. 2006. PMID: 17165174 Review. Polish. No abstract available.
-
The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.Postgrad Med. 2009 Jan;121(1):59-72. doi: 10.3810/pgm.2009.01.1955. Postgrad Med. 2009. PMID: 19179814 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical